Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 31, 491-495, May 1, 1971]
© 1971 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rogers, A. E.
Right arrow Articles by Newberne, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rogers, A. E.
Right arrow Articles by Newberne, P. M.

Absence of an Effect of Partial Hepatectomy on Aflatoxin B1 Carcinogenesis1

Adrianne E. Rogers, Nora S. Kula and Paul M. Newberne

Department of Nutrition and Food Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139

The effect of partial hepatectomy on aflatoxin B1 (AFB1) carcinogenesis in rat liver has been examined in Fischer and Sprague-Dawley rats. Partial hepatectomy performed before or after the administration of AFB1 had no effect on the development of hepatocarcinoma, compared to either sham hepatectomy or no operation. When AFB1 administration was begun 6 hr after either hepatectomy or sham operation, the incidence of carcinoma was less than that found when AFB1 treatment was begun between 24 hr and 6 days after surgery. Sprague-Dawley rats were less sensitive than Fischer rats to the carcinogenic effects of AFB1.

1 This work was supported in part by USPHS Grant RO1-AM-CA-11158 from the National Institute of Arthritis and Metabolic Diseases and USPHS Grant RO1-CA-08870 from the National Cancer Institute.

Received 10/16/70. Accepted 1/20/71.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1971 by the American Association for Cancer Research.